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Abstract
Neurons of the PNS are able to regenerate injured axons, a process requiring significant cellular resources to
establish and maintain long-distance growth. Genetic activation of mTORC1, a potent regulator of cellular
metabolism and protein translation, improves axon regeneration of peripheral neurons by an unresolved mech-
anism. To gain insight into this process, we activated mTORC1 signaling in mouse nociceptors via genetic
deletion of its negative regulator Tsc2. Perinatal deletion of Tsc2 in nociceptors enhanced initial axon growth after
sciatic nerve crush, however by 3 d post-injury axon elongation rate became similar to controls. mTORC1
inhibition prior to nerve injury was required to suppress the enhanced axon growth. Gene expression analysis in
purified nociceptors revealed that Tsc2-deficient nociceptors had increased activity of regeneration-associated
transcription factors (RATFs), including cJun and Atf3, in the absence of injury. Additionally, nociceptor deletion
of Tsc2 activated satellite glial cells and macrophages in the dorsal root ganglia (DRG) in a similar manner to nerve
injury. Surprisingly, these changes improved axon length but not percentage of initiating axons in dissociated
cultures. The pro-regenerative environment in naïve DRG was recapitulated by AAV8-mediated deletion of Tsc2
in adult mice, suggesting that this phenotype does not result from a developmental effect. Consistently,
AAV8-mediated Tsc2 deletion did not improve behavioral recovery after a sciatic nerve crush injury despite initially
enhanced axon growth. Together, these data show that neuronal mTORC1 activation induces an incomplete
pro-regenerative environment in the DRG that improves initial but not later axon growth after nerve injury.
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Significance Statement
Long-distance axon regeneration poses a significant hurdle to recovery following nervous system injury.
Increased mTORC1 signaling improves axon regeneration, however the underlying mechanisms are incom-
pletely understood. We activated neuronal mTORC1 signaling by genetically deleting Tsc2 in Nav1.8-
positive neurons perinatally or by AAV8-mediated viral infection in adult mice and observed improved short-
but not long-term axon regeneration after sciatic nerve injury. We suggest that Tsc2 deletion promotes initial
but not later peripheral axon regeneration by upregulating expression of neuronal pro-regenerative genes
and activating non-neuronal responses in the surrounding environment. Activating mTORC1 signaling in
peripheral neurons may provide therapeutic benefit in circumstances with poor initial growth such as after
spinal cord injury to the dorsal column or peripheral nerve repair.
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Introduction
Long-distance regeneration of injured axons poses an
insurmountable challenge for adult neurons of the CNS,
yet one that peripheral axons can overcome. Lack of
regeneration after axon injury results in potentially devas-
tating motor, cognitive, emotional and social deficits in-
curred from CNS insults such as stroke and spinal cord
injury. In contrast, functional recovery can be achieved in
the PNS after injury. However, long-term denervation of
distal nerve and/or target tissue negatively impacts recov-
ery (Gordon et al., 2011), which can occur in proximal
injuries requiring very long-distance axon growth. In the
regeneration-competent PNS, local protein synthesis in
the injured axon is required to form a growth cone and
promote initial growth of the axon (Bradke et al., 2012).
Calcium and retrograde signaling from the injury site to
the cell body establish a pro-regenerative gene expres-
sion program that is required to maintain long-distance
axon growth (Mahar and Cavalli, 2018). In addition to the
neuronal response, glia and immune cells provide trophic
support and debris clearance (Huang et al., 2013; Christie
et al., 2015; Krishnan et al., 2018; Jessen and Arthur-
Farraj, 2019; Zigmond and Echevarria, 2019). Establish-
ment of a full regeneration program in PNS is not evident
for 3–7 d following injury, and as such, initial rate of axon
elongation is notably less than rates at later time points
(Smith and Skene, 1997; Lankford et al., 1998). Under-
standing a pathway’s role in initiation and/or elongation
rate of regenerating axons is critical to evaluate its poten-
tial as a therapeutic target to improve functional recovery
after PNS injury.
Activation of mTORC1 signaling through genetic dele-
tion of negative regulators such as Pten, Tsc1, or Tsc2
improves axon regeneration in both the CNS and PNS
(Park et al., 2008; Abe et al., 2010; Liu et al., 2010; Lee
et al., 2014). mTORC1 signaling is a major effector of
cellular growth through positive regulation of cellular me-
tabolism and protein translation while also inhibiting pro-
tein turnover (Saxton and Sabatini, 2017). As such,
mTORC1 may play a role in both initiation and elongation
of axons. Initiation of CNS axon regeneration can be
conferred by mTORC1 activation (Park et al., 2008; Liu
et al., 2010); however, combining mTORC1 activation with
dysregulation of other pathways including Stat3, B-raf,
and c-Myc confer additional axon growth benefit over
mTORC1 activation alone (Sun et al., 2011; O’Donovan
et al., 2014; Belin et al., 2015). This suggests mTORC1
activation alone is not sufficient for CNS axons to achieve
their full regenerative potential. The role of mTORC1 in
peripheral axon regeneration is less clear. mTORC1 sig-
naling in sensory axons is required for formation of a
growth cone as well as retrograde survival signals after
axon injury (Verma et al., 2005; Terenzio et al., 2018).
While mTORC1 inhibition does not affect early axon re-
generation in vivo, it does reduce axon growth of sensory
neurons after a conditioning injury (Abe et al., 2010; Chen
et al., 2016), suggesting mTORC1 may be required during
later stages of axon regeneration. While genetic mTORC1
activation in sensory neurons enhances axon regenera-
tion within 2 d after nerve injury (Abe et al., 2010), its effect
on long-term regeneration and underlying mechanism re-
main to be resolved. As genetic mTORC1 activation in
nociceptors does not induce baseline hypersensitivity
(Carlin et al., 2018), this pathway may be of therapeutic
relevance in promoting recovery after PNS injury. In the
present study, we sought to evaluate the mechanism by
which genetic mTORC1 activation improves PNS axon
regeneration after nerve injury and to determine whether
this mechanism can be recapitulated in adult mice.
Materials and Methods
Experimental design and statistical analyses
Full details for individual experiments are noted below.
In general, analysis was performed by pooling near-equal
numbers of male and female mice from at least two litters
comparing homozygous Tsc2 deletion to heterozygous
littermate controls. Experimenters performing surgery and
behavioral observations were blind to genotype. Image
analysts were blind to both genotype and injury status.
RNA sequencing (RNA-seq) analysis was performed with
DESeq2 as described below. For all other experiments,
GraphPad Prism software was used for statistical analysis
with the appropriate tests, replicate numbers and statis-
tical values cited in the extended figures. Statistical sig-
nificance was defined by p  0.05. All error bars denote
SEM. Values of individual biological replicates are plotted
for most experiments.
Animals and procedures
All animal procedures and treatments were performed
in accordance with the Washington University School of
Medicine Institutional Animal Care and Use Committee’s
regulations. Mice were housed in an AAALAC-accredited
animal facility with 12/12 h light/dark cycles and ad libitum
access to food and water. Tsc2fl/fl (floxed allele; RRID:
MGI:3712786; Hernandez et al., 2007), Tsc2null/ (targeted
null allele; RRID:MGI:2174787; Onda et al., 1999),
Nav1.8Cre/ (also known as SNS-Cre, MGI:3042874;
Agarwal et al., 2004), and Rosa26-ZsGreen (also known
as Ai6(RCL-ZsGreen), RRID:IMSR_JAX:007906; Madisen
et al., 2010) mice were described previously. For Tsc2
deletion mediated by Nav1.8-Cre, mice with genotype
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Nav1.8Cre/; Tsc2null/ were crossed with Tsc2fl/fl mice.
Nav1.8Cre/; Tsc2null/fl mice are referred to as Tsc2 cKO
mice. Littermate animals with genotypes Tsc2fl/, Tsc2null/fl,
and Nav1.8Cre/; Tsc2fl/ were pooled as controls as they
showed no phenotypic differences from each other. For
AAV8-mediated deletion of Tsc2, mice with the genotypes
Tsc2fl/; Rosa26-ZsGreenGFP/GFP and Tsc2fl/fl; Rosa26-
ZsGreenGFP/GFP were used as control and experimental
(Tsc2 KO-AAV8) animals, respectively. Genotype was de-
termined by PCR at weaning. Adult male and female mice
aged 7–18 weeks were used for experiments.
For nerve injury experiments, mice were anesthetized
with 2.5% isoflurane. Subcutaneous injection of 1 mg/kg
buprenorphine SR-LAB (ZooPharm) was administered as
an analgesic. The right thigh was shaved and disinfected
with povidone-iodine solution (Ricca) and alcohol preps.
The sciatic nerve was exposed and crushed with 10 s of
full pressure from a #5 forceps (Fine Science Tools) or
transected with scissors. For sham surgeries, the sciatic
nerve was exposed but not crushed. For in vivo condi-
tioning experiments, the second crush was performed 5
mm proximal to the initial crush site. The wound was
closed with 6-0 Ethilon sutures and wound clips, which
were removed at 7 d post-surgery for behavior experi-
ments. For behavioral recovery experiments, mice were
anesthetized via intraperitoneal injection of a 0.25 ml of
100 mg/ml ketamine and 0.5 mg/ml dexmedetomidine
and resuscitated following surgery with 0.1 ml intraperi-
toneal Antisedan and 0.1 ml of 1 mg/kg solution of bu-
prenorphine sustained release.
Rapamycin (LC Laboratories catalog #53123-88-9) was
dissolved in ethanol diluted in 5% Tween 80, 5% PEG-
400. Daily injections of vehicle or 5 mg/kg rapamycin were
administered by subcutaneous injection.
For AAV8-mediated gene deletion, seven-week-old
mice were anesthetized with 2.5% isoflurane and re-
ceived intrathecal injections of AAV8-Cre-IRES-GFP un-
der the CMV promoter according to previously reported
methods (Njoo et al., 2014). Briefly, a 0.3-ml syringe with
a 31-G needle was inserted between the groove of the L5
and L6 vertebrae, with the bevel of the needle facing in the
rostral direction. After an observable tail flick indicative of
needle entry into the intradural space, 5 l of AAV8 was
injected intrathecally, and the needle was left in place for
1 min before withdrawal. A second dose was adminis-
tered 24 h later. Sciatic nerve crush surgery was per-
formed three weeks after initial dose.
Tissue processing and immunohistochemistry
Following euthanasia, mice were transcardially per-
fused with PBS followed by 4% paraformaldehyde in PBS
(FD Neurotechnologies catalog #PF101). Sciatic nerve
and/or L4 dorsal root ganglia (DRG) were isolated and
immersed in 4% paraformaldehyde. Tissue was washed
and cryoprotected in 30% sucrose. Frozen sections of 12
or 18 m were obtained on a Leica CM1860 cryostat for
nerve and DRG, respectively.
Immunostaining was performed as follows. Following a
brief post-fixation in 4% paraformaldehyde and several
washes in PBS with 0.1% Triton X-100 (PBSTx), sections
were blocked using 5% donkey serum dissolved in PB-
STx. Subsequently, sections were incubated overnight at
4°C in primary antibodies diluted in blocking reagent:
Tsc2 (D93F12, 1:200; Cell Signaling catalog #4308, RRID:
AB_10547134), SCG10/Stmn2 (1:1000; Novus catalog
#NBP1-49461, RRID:AB_10011569), cJun (1:250; Cell
Signaling catalog #9165, RRID:AB_2130165), Atf3 (1:250;
Novus catalog #NBP1-85816, RRID:AB_11014863), Islet1
(1:500; R and D Systems catalog #AF1837, RRID:
AB_2126324), Gfap (1:1000; Agilent catalog #Z0334,
RRID:AB_10013382), and Iba1 (1:1000; Wako catalog
#019-19741, RRID:AB_839504). Griffonia simplicifolia iso-
lectin B4 (IB4) directly conjugated to Alexa Fluor 488 or
Alexa Fluor 594 (1:250; Thermo Fisher Scientific catalog
#I21411 and #I21413) was incubated with primary anti-
bodies. Tubb3/III tubulin antibody (BioLegend catalog
#802001, RRID:AB_291637) was directly conjugated to
Alexa Fluor 594 or Alexa Fluor 647 using Apex labeling kit
(Thermo Fisher Scientific) and incubated with primary
antibodies at 1:200 dilution. Tissue was washed several
times with PBSTx, incubated with fluorescent-conjugated
secondary antibodies (1:500; Thermo Fisher Scientific)
and DAPI (1:1000) diluted in blocking reagent, washed
and mounted in ProLong Gold antifade mountant (Thermo
Fisher Scientific). Images were taken with a Nikon TE-
2000E compound microscope and Prior ProScan3 motor-
ized stage, which automatically stitched images in Nikon
Elements software. Images were analyzed using FIJI soft-
ware (NIH).
Image analysis
For sciatic nerve regeneration experiments, the crush
site was determined visually in images by highest levels of
SCG10 and confirmed by regional increased binding of
IB4 (data not shown). A vertical line was drawn at the
crush site, and the longest 10 axons were measured from
this line and averaged. Three sections were averaged to
establish the value of the longest axons for each biolog-
ical replicate.
For cell counting experiments, total number of neurons
as determined by the number of Tubb3-positive or Islet1-
positive profiles as well as the number of marker-positive
profiles were determined for each section. Only sections
with 80 neurons were scored. The numbers of cells in
each category for three sections were summed to gener-
ate a percentage of neurons expressing the marker(s) for
each biological replicate.
To determine macrophage density, profiles double-
positive for DAPI and Tubb3 were counted, and the area
immediately surrounding the counted neurons was out-
lined. Images were thresholded for Iba1 immunoreactivity
in a blinded manner and made binary. Iba1-positive area
was determined in square pixels. The Iba1-positive area
was summed for three sections and normalized to the
total number of neurons in the regions of interest for each
biological replicate. Simple area fraction was not used
because of differences in neuronal cell size as a result of
Tsc2 deletion (Carlin et al., 2018).
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For satellite glial cell activation, profiles double-positive
for DAPI and Tubb3 were counted. The percentage of
those neurons that had Gfap-positive signal on at least
two sides of the neuron cell body was determined and
reported. Only sections with 80 neurons were scored.
The numbers of cells in each category for three sections
were summed to generate a percentage of neurons sur-
rounded by Gfap for each biological replicate.
Flow cytometry and RNA-seq analysis
Flow cytometry and gene expression analysis were
characterized previously (Carlin et al., 2018). Uninjured
control and Tsc2 cKO data from that study were reana-
lyzed for the present study. Briefly, L4 DRG from
Nav1.8Cre/; Tsc2fl/; Rosa26-ZsGreenGFP/ (control) and
Nav1.8Cre/; Tsc2fl/null; Rosa26-ZsGreenGFP/ (Tsc2 cKO)
contralateral and ipsilateral to a sciatic nerve crush were
isolated 3 d after injury, dissociated as above, passed
through a 70-m cell strainer, resuspended in PBS with
2% fetal calf serum and subjected to flow cytometry. Cells
were run through an 85-m nozzle at 45 psi on a BD
FACS Aria II machine.
A total of 100 L4 DRG cells were FACS-sorted for GFP
signal into 9 l Clontech lysis buffer with 5% RiboLock
RNase Inhibitor for each sample. Three technical repli-
cates of 100 cells each were sorted. All samples were
submitted to the Genome Technology Access Center at
Washington University School of Medicine for library
preparation and sequencing. Libraries were prepared and
sequenced separately for each technical replicate. Library
preparation was performed using the SMARTer Ultra Low
RNA kit for Illumina Sequencing (Clontech) per manufac-
turer’s protocol. cDNA was amplified for 13 cycles and
then fragmented using a Covaris E220 sonicator using
peak incident power 18, duty cycle 20%, cycles/burst 50,
time 120 s at room temperature. cDNA was blunt ended,
had an A base added to the 3’ ends, and then had Illumina
sequencing adapters ligated to the ends. Ligated frag-
ments were then amplified for 15 cycles using primers
incorporating unique index tags. Fragments were se-
quenced on an Illumina HiSeq-3000 using single reads
extending 50 bases. Samples were QC’d using FastQC,
aligned to mm10 using STAR-align, and counted using
HTseq-count. Technical replicates were collapsed in
RStudio and differential expression determined using
DESeq2. The threshold for differential expression was
defined as adjusted p  0.05 and log2 fold change 0.5
or –0.5. The top differentially regulated Gene Ontology
(GO) categories and upregulated transcription factor tar-
get genes were determined using Metacore software
(Clarivate Analytics) with FDR threshold 0.05. oPOS-
SUM 3.0 was used for transcription factor binding site
analysis of upregulated genes for each condition relative
to uninjured control (Kwon et al., 2012). For transcription
factor binding site analysis, JASPAR CORE profiles were
used with all 29,347 genes in the oPOSSUM database as
background genes. 5000 base-pairs of upstream and
downstream sequence were analyzed.
RNA-seq FastQ and HTseq-count files were deposited
at the NCBI GEO database (https://www.ncbi.nlm.nih-
.gov/geo/) under accession numbers GSE112499 (Carlin
et al., 2018) and GSE125685 (present study).
Western blotting
Adult L4/L5 DRG or sciatic nerves were isolated and
manually homogenized in 2% sodium dodecyl sulfate in
60 mM Tris, pH 6.8 with protease and phosphatase inhib-
itors (Roche Applied Sciences). Protein concentration was
determined by DC protein assay (Bio-Rad Laboratories)
against bovine serum albumin standards. Twelve- to
15-g total protein was loaded onto 4–12% Bis-Tris poly-
acrylamide gels (Invitrogen). Nitrocellulose membranes
were blotted with antibodies directed against the follow-
ing proteins: -tubulin (1:20,000; Abcam catalog
#ab18251, RRID:AB_2210057), cJun (1:1000; Cell Signal-
ing catalog #9165, RRID:AB_2130165), phospho-S6
S240/244 (1:1000; Cell Signaling Technology catalog
#5364, RRID:AB_10694233), S6 (1:1000; (Cell Signaling
Technology catalog #2217, RRID:AB_331355), Atf3 (1:
1000; Novus catalog #NBP1-85816, RRID:AB_11014863),
phospho-Stat3 Y705 (1:1000; Cell Signaling Technology
catalog #9131, RRID:AB_331586), Stat3 (1:1000; Cell Sig-
naling Technology catalog #12640, RRID:AB_2629499),
and rabbit IgG conjugated to horseradish peroxidase (1:
10,000; Thermo Fisher catalog #656120). Initially, anti-
bodies for phosphorylated isoforms were probed,
membranes were stripped in 60 mM Tris-HCl, 2% sodium
dodecyl sulfate, pH 6.8 at 50°C for 30 min, washed ex-
tensively, and then probed for total protein. Blots were
developed with SuperSignal West Dura (ThermoFisher),
imaged with a ChemiDoc MP imaging system and quan-
tified with Image Lab 5.2.1 (Bio-Rad Laboratories). Vol-
ume intensity of markers was first normalized to -tubulin.
Log2 fold change of normalized values in relation to nor-
malized uninjured control value was determined for each
biological replicate.
Quantitative PCR
Adult L3 (rapamycin experiments) or L4/L5 (injury ex-
periments) DRG were isolated, lysed, and homogenized.
Total RNA was extracted with PureLink RNA Mini kit
according to manufacturer’s instructions (Thermo Fisher
Scientific). RNA concentration was determined by Nano-
Drop 2000 (Thermo Fisher Scientific). Samples were re-
verse transcribed with High Capacity cDNA Reverse
Transcription kit (Applied Biosystems). Quantitative PCR
(qPCR) was performed with PowerUp SYBR Green mas-
ter mix on 1 ng cDNA with a QuantStudio 6 Flex and
analyzed with QuantStudio Real-Time PCR Software v1.3
(Applied Biosystems). Average Ct value from three tech-
nical replicates per sample was normalized to average Ct
value of ribosomal protein L13a (Rpl13a) and Gapdh ref-
erence gene expression. -Ct values were determined in
reference to average uninjured control or vehicle control
Ct value. Validated primer sequences were obtained
from PrimerBank where available (Wang et al., 2012).
Additional primers were designed and validated for am-
plification efficiency by standard curve analysis. Single
amplified products were noted from melting point
analyses and agarose gel electrophoresis. Primer se-
quences are as follows: Rpl13a forward 5’-
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AGCCTACCAGAAAGTTTGCTTAC-3=, Rpl31a reverse 5’-
GCTTCTTCTTCCGATAGTGCATC-3=, Gapdh forward 5’-
AGGTCGGTGTGAACGGATTTG-3=, Gapdh reverse 5’-
TGTAGACCATGTAGTTGAGGTCA-3=, Gfap forward 5=-
GGGGCAAAAGCACCAAAGAAG-3=, Gfap reverse 5=-
GGGACAACTTGTATTGTGAGCC-3=, CD16 forward 5=-
TGTTTGCTTTTGCAGACAGG-3=, CD16 reverse 5=-
GCACCGGTATTCTCCACTGT-3=, CD32 forward 5=-
AGAAGCTGCCAAAACTGAGG-3=, CD32 reverse 5=-
GTGGTTCTGGTAATCATGCTCTG-3=, CD86 forward 5=-
TGTTTCCGTGGAGACGCAAG-3=, CD86 reverse 5=-
TTGAGCCTTTGTAAATGGGCA-3=, Arg1 forward 5=-
CTCCAAGCCAAAGTCCTTAGAG-3=, Arg1 reverse 5=-
AGGAGCTGTCATTAGGGACATC-3=, CD163 forward
5-ATGGGTGGACACAGAATGGTT-3=, CD163 reverse 5=-
CAGGAGCGTTAGTGACAGCAG-3=, CD206 forward 5=-
CTCTGTTCAGCTATTGGACGC-3=, CD206 reverse 5=-
CGGAATTTCTGGGATTCAGCTTC-3=, Trem2 forward 5=-
CTGGAACCGTCACCATCACTC-3=, Trem2 reverse 5=-
CGAAACTCGATGACTCCTCGG-3=.
Analysis of cultured DRG neurons
Sciatic nerve crush was performed on adult
Nav1.8Cre/; Tsc2fl/; Rosa26-ZsGreenGFP/ (control) and
Nav1.8Cre/; Tsc2fl/null; Rosa26-ZsGreenGFP/ (Tsc2 cKO)
mice. After 3 d, mice were euthanized and transcardially
perfused with Hanks’ balanced salt solution. Uninjured
and injury-conditioned L4 DRG were isolated in Hanks’
balanced salt solution with 10 mM HEPES (HBSS-H).
DRG were treated at 37°C with papain (15 U/ml, Wor-
thington Biochemical) and collagenase (1.5 mg/ml,
Sigma-Aldrich) in HBSS-H with intermittent HBSS-H
washes. DRG were dissociated by trituration, passed
through a 70-m cell strainer, and 1/4 of resuspended
cells were plated into two wells of a 24-well plate coated
with 100 g/ml poly-D-lysine and 3 g/ml laminin. Cell
were cultured in Neurobasal-A medium supplemented
with B27 plus, glutaMAX, and penicillin/streptomycin
(Thermo Fisher) at 37°C, 5% CO2.
After 24 h in culture, cells were fixed with 3% parafor-
maldehyde in PBS, washed with PBS, blocked with 5%
donkey serum dissolved in PBSTx and stained with IB4
directly conjugated to Alexa Fluor 488 (1:250; Thermo
Fisher Scientific catalog #I21411,) and Tubb3 antibody
(1:1000; BioLegend catalog #802001, RRID:AB_291637).
Cells were washed several times with PBS, incubated
with fluorescent-conjugated secondary antibody (1:1000;
Thermo Fisher Scientific) and DAPI (1:1000) diluted in
blocking buffer, washed and mounted in ProLong Gold
antifade mountant (Thermo Fisher Scientific). Images
were taken with a Nikon TE-2000E compound micro-
scope and Prior ProScan3 motorized stage, which auto-
matically stitched images in Nikon Elements. Images were
analyzed using FIJI software (NIH).
For percentage initiation, all neurons (Tubb3 and DAPI
double-positive profiles) in a single well were counted for
each biological replicate, categorized as IB4-positive,
GFP-positive or IB4-negative, GFP-positive or GFP-
negative, and the number of neurons initiating axon
growth was determined. Axon initiation was defined as
neurons with an axon greater than two cell diameters in
length. Radial length was measured from the center of the
neuron soma to the farthest point from the soma center
that its axon crosses from both wells from uninjured DRG
or from half of a well from injured DRG. Length measure-
ments were only recorded from neurons that initiated
axons as defined above.
Behavioral analysis
Mechanical sensitivity was determined with calibrated
von Frey filaments by using the up-and-down paradigm
(Chaplan et al., 1994). Briefly, each mouse was placed
individually under a polyacrylamide enclosure on a mesh
base and allowed to acclimate for 3 h. The hind limbs
were then tested with 0.32-g von Frey filaments. If the
animal responded to the stimulus, the filament strength
was decreased. Alternatively, if the animal did not re-
spond, the filament strength was increased. The 50%
withdrawal threshold was then calculated (Dixon, 1980).
Testing was conducted preoperatively, and then semi-
weekly for the duration of the study beginning after the
first postoperative week.
To assess cold allodynia, mice were placed individually
under a polyacrylamide enclosure on a mesh base and
allowed to acclimate for 3 h; 0.05–0.1 ml of acetone was
applied to the plantar aspect of the left hindlimb. The
animals were observed for 1 min. The total time of re-
sponse was recorded. The right leg was then tested. Both
hind limbs were tested for a total of five trials, and the total
time was averaged. A positive response included licking
of the plantar aspect of the leg or refusal to bear weight on
the affected limb. Testing was conducted preoperatively,
and then weekly for the duration of the study.
Results
Nociceptor deletion of Tsc2 improves axon
regeneration within 2 d of nerve injury in an
mTORC1-dependent manner
Long-distance axon regeneration requires sustained
protein translation, and mTORC1 is a potent regulator of
cellular growth and protein translation (Bradke et al.,
2012; Saxton and Sabatini, 2017; Terenzio et al., 2018).
Therefore, we hypothesized that activating mTORC1 in
nociceptive neurons, which do not regenerate as well as
non-nociceptive neurons (Kalous and Keast, 2010), could
both establish and maintain enhanced axon growth after a
peripheral nerve injury. We analyzed axon regeneration in
mice in which Tsc2 deletion was mediated by Nav1.8-Cre
(also known as SNS-Cre), which is predominantly ex-
pressed in nociceptors. Nav1.8-Cre drives specific, peri-
natal expression of Cre recombinase in 75% of all DRG
neurons, including 90% of C-fiber neurons and 40%
of A-fiber neurons, with no expression in non-neuronal
cells or CNS neurons (Agarwal et al., 2004; Shields et al.,
2012). Mice with perinatal Tsc2 deletion as a result of
Nav1.8-Cre are denoted as Tsc2 cKO. Using SCG10 to
specifically label regenerating axons (Shin et al., 2014), we
found that Tsc2 cKO mice showed improved axon regen-
eration 1 d after sciatic nerve crush, with further improve-
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ment by 2 d (sham/1 d: ctrl 0.89  0.05 mm vs Tsc2 cKO
1.53  0.05 mm; 2 d: ctrl 2.21  0.09 mm vs Tsc2 cKO
3.40  0.03 mm; Fig. 1B,C), consistent with our previous
results (Abe et al., 2010). However, analysis of axon re-
generation 3 d after nerve crush showed no additional
improvement (3 d: ctrl 4.42  0.11 mm vs Tsc2 cKO 5.58
 0.09 mm; Fig. 1C). These data suggest that Tsc2
deletion may only have an early effect on axon regenera-
tion.
After a peripheral nerve injury, retrograde signals from
the injury site induce a transcription-dependent regener-
ation program in DRG neurons within 24–48 h, whereby
the regenerative growth rate of axons increases with the
changes in neuronal gene expression (Smith and Skene,
1997; Mahar and Cavalli, 2018). We thus tested whether
the 1-d axon growth rate 3 d after a conditioning injury is
similar in control and Tsc2 cKO mice (Fig. 1A). In control
mice, injury-conditioned axons grew significantly longer
than sham, as expected (Shin et al., 2012). However,
injury-conditioned axon growth was not further improved
by deletion of Tsc2 (Fig. 1B,D). These data suggest that
the axon elongation rate of control axons catches up to
the initially enhanced rate of Tsc2-deficient neurons by 3
d post-injury.
Figure 1. Neuronal deletion of Tsc2 improves axon regeneration within the first 2 d following nerve injury. A, Scheme of in vivo
conditioning experiment. SN denotes sciatic nerve. B, SCG10 immunostaining of sciatic nerves 1 d after crush injury in control and
Tsc2 cKO mice with (conditioned) or without (sham) a conditioning injury. Red dotted line denotes the crush site while red arrowheads
point to the three longest axons. Scale bar: 500 m. C, Quantification of average of the ten longest axons at 1, 2, and 3 d following
a single sciatic nerve crush. D, Quantification of average of the ten longest axons at 1 d after sciatic nerve crush with (cond) and
without (sham) a conditioning injury 3 d prior from B. N.S., not significant, p 0.05, p 0.0001. Extended Data Figure 1-1 shows
data values of mean and SEM, number of replicates, statistical tests, and values for all comparisons.
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As Tsc2 deletion in nociceptors increases mTORC1
activity (Carlin et al., 2018), we sought to confirm that
enhanced axon growth in Tsc2-deficient neurons re-
sulted from increased mTORC1 signaling. To test this,
we compared axon regeneration 3 d after a sciatic
nerve crush in control and Tsc2 cKO mice that were
treated daily with vehicle or rapamycin starting at the
time of injury. Consistent with a previous study (Chen
et al., 2016), we found that axon regeneration was
insensitive to rapamycin in control mice (Fig. 2). Sur-
prisingly, we also observed that the enhanced regener-
ation in Tsc2 cKO mice was also insensitive to
rapamycin treatment post-injury (Fig. 2), suggesting
that acute mTORC1 signaling does not have a signifi-
cant role in improving regeneration. As Tsc2 deletion is
perinatal while injury occurs in adult mice, we hypoth-
esized that chronic mTORC1 activation may induce a
pro-regenerative state in neurons before injury. To test
this hypothesis, we assessed axon regeneration 3 d
after a sciatic nerve crush in control and Tsc2 cKO mice
that were treated daily with vehicle or rapamycin start-
ing 3 d before injury (before and after crush). Rapamy-
cin treatment starting 3 d before injury in Tsc2 cKO
mice showed a significant reduction of axon growth to
near vehicle-treated control lengths (Fig. 2). Axon
growth in control mice with pre-crush and post-crush
rapamycin treatment was slightly reduced compared to
similarly treated Tsc2 cKO mice (p  0.0009), which is
consistent with incomplete inhibition mTORC1 signal-
ing by rapamycin. Taken together, these results sug-
gest that nociceptor deletion of Tsc2 induces an
mTORC1-dependent, pro-regenerative program unin-
jured neurons.
Nociceptor deletion of Tsc2 induces pro-
regenerative gene expression in uninjured DRG
neurons
As our regeneration studies suggest that Tsc2-deficient
neurons are in a pro-regenerative state, we compared the
gene expression profiles of uninjured and injured control
and Tsc2 cKO neurons. We crossed control and Tsc2
cKO mice with a Rosa26-ZsGreen reporter line to label all
Nav1.8-positive neurons (Madisen et al., 2010; Carlin
et al., 2018). Uninjured and injured L4 DRG were dissoci-
ated 3 d after sciatic nerve injury, and three technical
replicates of 100 GFP-positive neurons were sorted by
flow cytometry for library preparation and RNA-seq. This
method enriched for neurons, specifically nociceptors,
and previous differential expression analysis comparing
uninjured control and Tsc2 cKO neurons uncovered dys-
regulation of a large number of sensory behavior-related
genes and ion channels (Carlin et al., 2018). Here, we
identified 8600 genes as differentially expressed by Tsc2
deletion and/or injury compared to uninjured control, with
similar gene expression changes in each condition (ad-
justed p 0.05; Fig. 3A; Extended Data Fig. 3-1). Of those
genes, 7000 exhibited a log2 fold change 0.5 or
–0.5, and were used for further downstream analysis.
Specifically, 62.5% and 42.5% of genes that were up-
regulated and downregulated after injury, respectively,
exhibited similar dysregulation in uninjured Tsc2 cKO
neurons (Fig. 3B). Additionally, we compared differentially
regulated GO molecular functions and pathways using
thresholded differentially expressed genes under each
condition relative to uninjured control neurons. The top
five differentially regulated GO molecular functions and
pathways after injury in control neurons were similarly
dysregulated in uninjured Tsc2 cKO neurons, albeit to a
Figure 2. mTORC1 inhibition before injury is required to suppress the enhanced axon regeneration in Tsc2 cKO mice. A, Injured
sciatic nerves stained with SCG10 to label regenerating axons 3 d after crush. Mice were treated daily with vehicle or rapamycin
beginning 3 d before injury. Vehicle and Pre Post Rapa denotes vehicle and rapamycin treatment, respectively, for all 6 d. Post Rapa
denotes vehicle treatment before injury and rapamycin treatment post-injury. Red dotted line denotes the crush site while red
arrowheads point to the three longest axons. Scale bar: 500 m. B, Quantification of average of the ten longest axons 3 d following
sciatic nerve crush from A. N.S., not significant, p  0.05, p  0.001. Extended Data Figure 2-1 shows data values of mean and
SEM, number of replicates, statistical tests, and values for all comparisons.
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lesser extent in several cases (Fig. 3C,D). While there are
clear similarities between Tsc2 deletion and nerve injury,
these analyses show that the overlap is not complete,
suggesting that Tsc2 deletion may induce a partial pro-
regenerative program.
A number of regeneration-associated transcription fac-
tors (RATFs) have been identified and characterized for
necessity and/or sufficiency to promote axon regenera-
tion in the PNS (Patodia and Raivich, 2012; Mahar and
Cavalli, 2018; Oh et al., 2018). Using these gene lists, we
assessed whether Tsc2 deletion affected gene expression
of RATFs in a similar manner as nerve injury in FACS-
sorted, Nav1.8-positive neurons. Indeed, many RATFs
exhibited increased expression after nerve injury in con-
trol neurons, including Atf3, cJun, Smad1, Sox11, Stat3,
Creb1, Rest, C/ebpd, Smad2, Klf6, and Klf7. Tsc2 dele-
tion was sufficient to increase expression of those RATFs
in the absence of injury with the exceptions of Creb1,
Rest, Klf6, and Klf7 (Fig. 4A). Our RNA-seq analysis un-
covered significant similarities of RATF expression
changes by Tsc2 deletion or nerve injury.
To assess whether RATF activity was also affected by
Tsc2 deletion and/or nerve injury, we assessed the up-
regulated genes under each condition relative to uninjured
control for overrepresentation of RATF target genes.
Target genes were identified from Metacore software da-
tabases (Clarivate Analytics). We observed overrepresen-
tation of RATF target genes for most RATFs after both
injury and Tsc2 deletion, including for RATFs that exhib-
ited no change of their own expression (Fig. 4A,B). Simi-
larly, transcription factor binding site analysis of
upregulated genes compared to uninjured control uncov-
ered similar RATF binding profiles after nerve injury or
Tsc2 deletion (Fig. 4C). From these analyses, we noted
four classes of RATFs in relation to their activity and
expression in uninjured Tsc2 cKO neurons. In the first
class (Fig. 4, far left), upregulated expression of the RATF
and overrepresentation of its target genes were observed
in Tsc2 cKO neurons. This group includes Atf3, cJun,
Hif1a, Smad1, Sox11, and Stat3. Notably, expression of
many RATFs in this category was upregulated to a lesser
extent as a result of Tsc2 deletion than after nerve injury.
The second class of RATFs exhibited increased activity
noted from overrepresentation of upregulated RATF tar-
get genes (Fig. 4, middle left), however RATF expression
itself was unaffected or even reduced in uninjured Tsc2
cKO neurons. This group includes c-Myc, Creb1, Klf4,
Rest, Srf, Trp53, and Xbp1. Rest is an intriguing member
Figure 3. Similar molecular pathways are induced in Nav1.8-positive neurons by injury and by Tsc2 deletion. A, Heat map of
differentially expressed genes in FACS-sorted, Nav1.8-positive neurons for each condition relative to uninjured control (n  4 total;
n  2 male; n  2 female; 8600 genes with adjusted p  0.05 in at least one condition). B, Venn diagrams showing differentially
expressed genes (adjusted p  0.05, log2 fold change 0.5 or –0.5) relative to uninjured control neurons for each condition. Total
number of differentially expressed genes in each condition in parenthesis. C, D, Top five GO molecular functions and pathways
categories differentially regulated in crush control neurons and Tsc2 cKO. Extended Data Figure 3-1 shows genes differentially
expressed (adjusted p  0.05, log2 fold change 0.5 or –0.5) under at least one condition relative to uninjured control neurons.
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Figure 4. Tsc2 deletion upregulates expression of RATFs and their target genes in the absence of injury. A, Expression levels of RATFs
in FACS-sorted Nav1.8-positive neurons. Differential expression is noted relative to uninjured control. Differential expression with
adjusted p  0.05 is reported as 0 values. B, Interactome analysis of upregulated genes from FACS-sorted, Nav1.8-positive neurons
assessed for preferential upregulation of RATF target genes identified by Metacore software (threshold FDR 0.05). Interactions with
p  0.05 are reported as 0 values. C, Transcription factor binding site analysis using oPOSSUM 3.0 of upregulated genes relative to
uninjured control in FACS-sorted Nav1.8-positive neurons. Dotted lines denote classes of RATFs defined in Results. Log2 fold change
and p values for transcription factor expression changes can be found in Extended Data Figure 3-1.
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of this list as it is a transcriptional repressor and only
shows upregulated expression of target genes as a result
of Tsc2 deletion but not after injury. Similar to relative
expression of RATFs in the first class, overrepresentation
of upregulated target genes in this second class was more
extensive after nerve injury than as a result of Tsc2 dele-
tion. The third class of RATF contains Smad2 and C/ebpd
(Fig. 4, middle right). No overrepresentation of these RATF
target genes was observed as a result of Tsc2 deletion
despite an increase in their own expression. This class
shows activity in Tsc2 cKO neurons that is contradictory
to their activity post-injury in control neurons. Finally, Klf6
and Klf7 expression was increased after injury but not
Tsc2 deletion while their overrepresentation of their up-
regulated target genes was not notably affected under
any condition (Fig. 4, far right). This may be a result of
incomplete profiling of their target genes in the Metacore
software database. Together, these data show that ex-
pression and activity of several known RATFs are similarly
affected by nociceptor deletion of Tsc2 and by nerve
injury, suggesting that Tsc2 deletion primes neurons for
axon regeneration even in the absence of an injury.
Our data show that the rate of axon growth 3 d follow-
ing nerve injury was unaffected by Tsc2 deletion (Fig.
1B–D). As such, we predicted that expression profiling of
RATFs and their upregulated target genes in injured DRG
neurons would not show additive dysregulation as a result
of Tsc2 deletion. Indeed, for virtually all RATFs analyzed,
RATF and target gene expression were affected to similar
degrees by injury in both control and Tsc2 cKO neurons
(Fig. 4A–C). Therefore, we conclude that Tsc2 deletion in
uninjured DRG neurons establishes a partial pro-
regenerative gene expression landscape, but Tsc2 dele-
tion does not further enhance the regenerative state of
injured neurons.
Nociceptor deletion of Tsc2 upregulates cJun and
Atf3 expression in IB4-positive neurons
cJun and Atf3 have been shown to be both necessary
and sufficient to promote axon regeneration in peripheral
nerves (Raivich et al., 2004; Seijffers et al., 2007; Ruff
et al., 2012; Fagoe et al., 2015; Chandran et al., 2016; Gey
et al., 2016), and mTORC1 signaling affects expression of
these RATFs in other cell types (Nie et al., 2015; Norrmén
et al., 2018). To validate our sequencing results, we
counted cJun-positive and Atf3-positive neuronal nuclei
in uninjured and injured DRG 3 d after a sciatic nerve
transection. We observed an increased number of cJun-
positive and Atf3-positive neuronal nuclei in uninjured
Tsc2 cKO DRG, but notably less than the amount of
positive nuclei after an injury (Fig. 5A–D), consistent with
our RNA-seq analysis (Fig. 4A). These data suggest a cell
type-specific response to Tsc2 deletion. Calcitonin gene-
related peptide (CGRP) and G. simplicifolia IB4 are com-
mon markers to positively identify peptidergic and
nonpeptidergic classes of nociceptors, respectively. Tsc2
deletion alters the distribution of these neuronal subtypes
with an expansion in the number of IB4-positive neurons
and reduction in the number of CGRP-positive neurons as
well as reduced CGRP expression (Carlin et al., 2018). To
positively identify nonpeptidergic nociceptors and deter-
mine whether cJun or Atf3 expression was preferentially
upregulated in these neurons, we labeled DRG for IB4
binding. After injury, cJun and Atf3 nuclear localization
increased in both IB4-positive and IB4-negative neurons
to similar extents; however, in uninjured Tsc2 cKO DRG
the vast majority of neurons showing increased cJun and
Atf3 nuclear localization were IB4-positive (Fig. 5A–D).
Despite the ubiquitous expression of Tsc2 in DRG neu-
rons, IB4-positive neurons preferentially upregulated cJun
and Atf3 expression in response to Tsc2 deletion.
As rapamycin pre-treatment reduced the enhanced
axon regeneration in Tsc2 cKO mice, we assessed
whether increased cJun or Atf3 expression was affected
by 3 d of daily rapamycin treatment in uninjured control
and Tsc2 cKO DRG. Phosphorylation of ribosomal protein
S6 is a downstream marker of mTORC1 activity, and it
was strongly reduced by rapamycin treatment in both
control and Tsc2 cKO DRG (Fig. 5E,F). Rapamycin treat-
ment also partially reduced protein expression of cJun
and Atf3 in Tsc2 cKO DRG (Fig. 5E,F), suggesting that the
pro-regenerative gene expression induced by Tsc2 dele-
tion can be suppressed by mTORC1 inhibition.
Nociceptor deletion of Tsc2 induces pro-
regenerative non-neuronal responses
Recent studies have revealed a role for non-neuronal
cells in promoting axon regeneration, especially macro-
phages. Macrophages infiltrate and become activated in
DRG after nerve injury, and this process is necessary and
sufficient to promote axon outgrowth similar to injury
conditioning (Kwon et al., 2013, 2015; Niemi et al., 2013,
2016; Krishnan et al., 2018; Zigmond and Echevarria,
2019). We thus assessed the density of Iba1-positive
macrophages in the DRG after injury or as a result of
neuronal Tsc2 deletion. Tsc2 deletion and injury both
increased macrophage density to similar extents, and this
phenotype was additive in the injured Tsc2 cKO DRG (Fig.
6A,B). It has been previously reported that the predomi-
nant activation state of DRG macrophages after injury is
the M2 phenotype (Kwon et al., 2015; Niemi et al., 2016).
To determine the phenotype of DRG macrophages as a
result of neuronal Tsc2 deletion, we analyzed M1 and M2
macrophage markers by qPCR of whole DRG. The ex-
pression levels of M1 markers CD16, CD32, and CD86 as
well as the M2 markers Arg1, CD206, and Trem2 were
upregulated by both Tsc2 deletion and injury, contrary to
a previous study showing an M2 bias at the same time
point (Fig. 6E; Kwon et al., 2013). The M2 marker CD163
was upregulated only after injury but not by Tsc2 deletion
suggesting that the M2 phenotype may be incomplete.
Additional markers such as Nos2 and Il10 were undetect-
able in uninjured control DRG. Consistent with the in-
creased macrophage density in injured Tsc2 cKO DRG,
we also observed further upregulation of Arg1 and Trem2
expression in injured Tsc2 cKO DRG compared to injured
control DRG (Fig. 6E).
Ccr2-mediated activation of M2 macrophages via Ccl2
signaling is both necessary and sufficient to promote
axon regeneration (Kwon et al., 2015; Niemi et al., 2016).
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Figure 5. Nociceptor deletion of Tsc2 preferentially upregulates cJun and Atf3 expression in IB4-positive neurons. A, Immunohis-
tochemistry of L4 DRG contralateral and ipsilateral to a sciatic nerve transection (SN injury) at 3 d post-injury stained for cJun, Isl1
(all neurons), and IB4. Arrows point to cJun-positive, IB4-negative neurons, and arrowheads point to cJun, IB4 double-positive
neurons in uninjured Tsc2 cKO DRG. Scale bars: 50 m. B, Quantification of percentage of cJun-positive neurons from A. C,
Immunohistochemistry of L4 DRG for Atf3, Isl1 (all neurons) and IB4. Arrows point to Atf3-positive, IB4-negative neurons and
arrowheads point to Atf3, IB4 double-positive neurons in uninjured Tsc2 cKO DRG. Scale bars: 50 m. D, Quantification of
percentage of Atf3-positive neurons from C. E, Western blotting of uninjured control and Tsc2 cKO L4/L5 DRG from mice receiving
daily vehicle or rapamycin treatment for 3 d. F, Quantification of protein expression from E. Log2 fold change relative to uninjured
control from the same biological replicate. N.S., not significant, p 0.05, p 0.01, p 0.001, p 0.0001. Extended Data
Figure 5-1 shows data values of mean and SEM, number of replicates, statistical tests, and values for all comparisons.
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Figure 6. Nociceptor deletion of Tsc2 activates macrophages and satellite glial cells in DRG. A, Immunohistochemistry of L4 DRG
contralateral and ipsilateral to a sciatic nerve transection (SN injury) at 3 d post-injury stained for Iba1 and Tubb3. Scale bar: 50 m.
B, Quantification of macrophage density by Iba1-positive area per neuron from A. C, Immunohistochemistry of L4 DRG contralateral
and ipsilateral to a sciatic nerve transection (SN injury) at 3 d post-injury stained for Gfap and Tubb3. Scale bar: 50 m. D,
Quantification of percentage of neurons surrounded by Gfap staining on at least two sides from C. E, qPCR of L4/L5 DRG
contralateral or ipsilateral to sciatic nerve crush at 3 d post-injury for markers of activated satellite glial cells (SGC), M1, or M2
macrophages. F, qPCR for markers of macrophage or SGC activation in L3 DRG from mice receiving daily vehicle or rapamycin
treatment for 3 d. Normalized to uninjured control. N.S. or N, not significant, p  0.05, p  0.01, p  0.001, p  0.0001.
Extended Data Figure 6-1 shows data values of mean and SEM, number of replicates, statistical tests, and values for all comparisons.
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To determine whether Ccr2 activation is responsible for
macrophage recruitment and activation in uninjured Tsc2
cKO DRG, we assessed the differential gene expression
of Ccr2 ligands Ccl2, Ccl7, Ccl8, and Ccl11 in our RNA-
seq dataset (Extended Data Fig. 3-1). Ccl2, Ccl7, and
Ccl11 were not differentially expressed after injury, andCcl2
expression was reduced while Ccl7 and Ccl11 expression
remained unchanged in uninjured Tsc2 cKO neurons com-
pared to uninjured control neurons (Ccl2: –2.1  0.6 log2
fold change in uninjured Tsc2 cKO, adjusted p  0.0037;
Ccl2: –0.8 0.6 log2 fold change in crush control, adjusted
p  0.3456). However, Ccl8 expression was increased un-
der all conditions compared to uninjured control neurons
(Ccl8: 2.2  0.8 log2 fold change in uninjured Tsc2 cKO,
adjusted p  0.0190; Ccl8: 3.5  0.8 log2 fold change in
crush control, adjusted p  9.18E-05), suggesting that Ccl8
may have a role in macrophage recruitment and activation in
DRG as a result of nerve injury and/or neuronal Tsc2 dele-
tion. Together, these data show that in the absence of an
injury, neuronal deletion of Tsc2 induces a non-neuronal
response in DRG with macrophage recruitment and activa-
tion similar to an injured state.
Although the exact role of satellite glial cells in axon
regeneration remains unclear, these cells encircle DRG neu-
ron cell bodies and react to nerve injury by upregulating
Gfap expression (Fenzi et al., 2001; Hanani, 2005; Xie et al.,
2009; Ji et al., 2013; Christie et al., 2015; Krishnan et al.,
2018). We observed a dramatic increase in Gfap expression
surrounding neurons in response to Tsc2 deletion, well be-
yond its expression 3 d post-injury in control DRG, by both
qPCR and immunohistochemistry (Fig. 6C–E). These results
suggest that satellite glial cells are strongly activated by
neuronal Tsc2 deletion. In addition to the region surrounding
the neuronal cell bodies, we also observed increased ex-
pression in regions enriched for axons, suggesting in-
creased Gfap expression in Schwann cells as well.
To assess whether non-neuronal activation may con-
tribute to the enhanced regeneration in Tsc2 cKO mice,
we assessed if these phenotypes were sensitive to
mTORC1 inhibition by rapamycin in uninjured L3 DRG.
Vehicle-treated Tsc2 cKO L3 DRG showed similar up-
regulation of Gfap, M1 and M2 markers as untreated L4
DRG (Fig. 6E,F). Surprisingly, Gfap expression as well as
M1 macrophage activation in Tsc2 cKO DRG were unaf-
fected by rapamycin treatment (Fig. 6F). M2 macrophage
markers CD206 and Trem2 in Tsc2 cKO DRG were unaf-
fected by rapamycin treatment, however Arg1 expression
returned to vehicle-treated control levels (Fig. 6F). This
suggests a complex effect of mTORC1 inhibition on the
M2 macrophage phenotype. Stat3 was shown to promote
enhanced axon growth downstream of Ccr2-mediated
macrophage activation in DRG (Niemi et al., 2016). Con-
sistent with maintained macrophage activation in
rapamycin-treated Tsc2 cKO DRG, we did not observe a
reduction in Stat3 phosphorylation compared to vehicle-
treated Tsc2 cKO DRG (Fig. 5E,F). Together, these data
suggest that mTORC1 inhibition in Tsc2 cKO mice incom-
pletely suppresses the upregulated neuronal and non-
neuronal pro-regenerative gene expression.
Nociceptor deletion of Tsc2 increases axon length but
not the percentage of neurons initiating axons in vitro
As neuronal Tsc2 deletion and nerve injury activate
similar neurons and non-neuronal responses, we tested
whether these conditions have similar effects on axon
growth in culture. A conditioning injury increases both the
percentage of neurons that initiate axons as well as the
length of those axons (Smith and Skene, 1997; Lankford
et al., 1998). We therefore dissociated L4 DRG neurons
from control and Tsc2 cKO adult mice with or without a
conditioning injury and analyzed axon growth after 24 h in
vitro. Analysis of all neurons from uninjured Tsc2 cKO
DRG showed no change in the percentage of neurons
initiating axons despite increased axon length, while a
conditioning injury increased both parameters relative to
uninjured control neurons (Fig. 7). These data suggest that
the pro-regenerative program induced by Tsc2 deletion is
incomplete.
As Nav1.8-Cre is expressed predominantly, but not
exclusively, in nociceptors and these neurons have been
shown to be insensitive to injury conditioning (Agarwal
et al., 2004; Kalous and Keast, 2010), we sought to con-
firm that nociceptors exhibit improved axon growth as a
result of Tsc2 deletion. We used control and Tsc2 cKO
mice crossed with Rosa26-ZsGreenGFP/ to analyze axon
growth in culture in GFP-positive neurons that are either
IB4-positive or IB4-negative, as well as in GFP-negative
neurons. Both IB4-positive and IB4-negative axons grew
longer as a result of Tsc2 deletion, however neither pop-
ulation showed an increased percentage of neurons initi-
ating axons (Fig. 7). Surprisingly, Tsc2 deletion and
conditioning injury produced an additive phenotype in
IB4-positive axon length (Fig. 7C). Contrary to previous
literature (Kalous and Keast, 2010), injury conditioning
increased both the percentage of initiating axons as well
as length in IB4-positive as well as IB4-negative control
neurons (Fig. 7). While multiple sensory neuron subtypes
including IB4-positive nociceptors showed improved
axon growth as a result of Tsc2 deletion, the induced
pro-regenerative program in insufficient to fully pheno-
copy injury conditioning.
The pro-regenerative activation of non-neuronal cells as
a result of nociceptor deletion of Tsc2 (Fig. 6) may induce
a conditioning effect on Nav1.8-negative neurons. To as-
sess this possibility, we analyzed in vitro axon growth in
GFP-negative neurons from Tsc2 cKO mice where Cre
expression, and consequently Tsc2 deletion, was not in-
duced. This GFP-negative population did not exhibit an
increased percentage of neurons with axons from unin-
jured Tsc2 cKO mice relative to control mice (Fig. 7A,B).
Length measurement of GFP-negative neurons from
uninjured DRG could not be obtained due to the very
low numbers of these cells initiating axons. However,
injury conditioning improved both percentage of initiat-
ing neurons as well as axon length in GFP-negative
neurons (Fig. 7), suggesting that Tsc2 deletion does not
induce a conditioning effect on wild type neurons in the
same DRG.
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Tsc2 deletion in adult mice induces a pro-
regenerative DRG landscape and initial regenerative
axon growth without improving functional recovery
Nociceptor-specific deletion of Tsc2 occurred perina-
tally in Tsc2 cKO mice and was accompanied by signifi-
cant gene expression changes in adult DRG neurons
(Figs. 3, 4; Agarwal et al., 2004; Carlin et al., 2018). To
determine whether a pro-regenerative DRG environment
could be induced by adult deletion of Tsc2, both control
(Tsc2fl/) and experimental (Tsc2fl/fl) adult mice were in-
jected intrathecally with an adeno-associated virus (AAV8)
expressing Cre recombinase, hereafter referred to as
Figure 7. Nociceptor deletion of Tsc2 increases axon length but not percentage initiation in cultured neurons. A, Uninjured and
injury-conditioned (3 d) L4 DRG neurons from control and Tsc2 cKO mice crossed with Rosa26-ZsGreenGFP/ cultured for 24 h and
stained for neuronal tubulin (Tubb3) and IB4. Scale bar: 50 m. B, C, Quantification of the percentage of cultured neurons that grow
axons (B) and the radial length of those axons (C) from A. Radial length of uninjured GFP– neurons is not reported due to the number
of neurons growing axons being too low to be representative. N.S., not significant, p  0.05, p  0.01, p  0.001, p 
0.0001. Extended Data Figure 7-1 shows data values of mean and SEM, number of replicates, statistical tests, and values for all
comparisons.
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control-AAV8 and Tsc2 KO-AAV8, respectively. AAVs
have limited cell-type specificity, and Cre-mediated GFP
reporter expression from the Rosa26 locus confirmed that
neurons as well as non-neuronal cells were infected in
DRG. In control mice, Tsc2 protein expression was nearly
ubiquitous in DRG neurons. In contrast, we observed a
substantial reduction in the percentage of Tsc2-
expressing neurons 3.5 weeks post-infection in Tsc2 KO-
AAV8 mice, with  50% deletion in most cases (Fig.
8A,B). To confirm that gene deletion occurred in nocice-
ptive neurons as a result of AAV8-Cre infection, we quan-
tified the percentage of IB4-positive and CGRP-positive
neurons that co-express Cre-mediated GFP reporter ex-
pression. In Tsc2 KO-AAV8 mice, we observed 61.0 
5.9% of all L4 DRG neurons expressed GFP as a result of
AAV8-Cre infection. Similarly, 64.6 7.6% of IB4-positive
neurons and 64.9  6.6% of CGRP-positive neurons
co-express GFP (all vs IB4: p  0.1919; all vs CGRP: p 
0.2208; paired t test; N  5), suggesting that AAV8-Cre
can infect nociceptive neurons as efficiently as non-
nociceptive neurons in DRG. Although we cannot exclude
the possibility that Tsc2 deletion also occurred in non-
neuronal cells, intrathecal injections of AAV8-Cre effi-
ciently deleted Tsc2 in lumbar DRG neurons of adult mice.
To test whether Tsc2 deletion in adult mice induces a
pro-regenerative landscape in the DRG, we assessed
cJun and Atf3 expression as well as macrophage density
in uninjured DRG of control-AAV8 and Tsc2 KO-AAV8
mice 3.5 weeks post-infection. Adult deletion of Tsc2
induced an upregulation of cJun-positive and Atf3-
positive nuclei with a correlation between the amount of
RATF-positive neurons and infection efficiency (Fig.
8C–F). In contrast, increased macrophage density was
only noted in mice with the highest levels of Tsc2 deletion
(Fig. 8G,H; images from mice with high infection effi-
ciency). Macrophage density appeared similar in control-
AAV8 and Tsc2 KO-AAV8 with  40% Tsc2-positive
neurons, suggesting a threshold level of gene deletion is
required for non-neuronal activation. These results show
that deletion of Tsc2 in adult mice is sufficient to induce a
pro-regenerative environment in DRG, albeit less potently
than genetic deletion in Tsc2 cKO mice.
We next tested whether the pro-regenerative environ-
ment in Tsc2 KO-AAV8 mice was capable of enhancing
initial axon growth after sciatic nerve crush. We analyzed
axon length in control-AAV8 and Tsc2 KO-AAV8 sciatic
nerves 3 d after a crush injury. Similar to genetic deletion
of Tsc2, the longest regenerating axons grew a farther
distance in Tsc2 KO-AAV8 nerve compared to control
nerve (Fig. 9A,B), with the length of axon regeneration at
3 d post-injury being similar in Tsc2 cKO and Tsc2 KO-
AAV8 mice (compare Figs. 1D, 9B). Unlike expression of
RATFs and macrophage density, increased infection effi-
ciency did not correlate with increased axon length in
Tsc2 KO-AAV8 (Fig. 9C), suggesting that mTORC1 acti-
vation in a relatively low number of neurons is sufficient to
observe enhanced axon growth at 3 d post-injury.
We next assessed whether the enhanced initial axon
regeneration mediated by adult deletion of Tsc2 improved
functional recovery. The efficiency of Tsc2 deletion was
unchanged after this 10-week experiment compared to
the 3.5-week axon regeneration experiment (3.5 weeks
36.8  5.3% Tsc2-positive neurons vs 10 weeks 33.7 
5.2% Tsc2-positive neurons). After a sciatic nerve crush,
sensitivity to a mechanical stimulus in the foot pad is
reduced from loss of innervating axons, which resolves
over several weeks as injured axons re-innervate target
tissue. Adult deletion of Tsc2 did not affect the course of
recovery of mechanical sensitivity (Fig. 9D). Specifically,
mice lost mechanical sensitivity initially after sciatic nerve
crush with control-AAV8 and Tsc2 cKO-AAV8 mice recov-
ering at the same rate.
In our previous study, we observed that Tsc2 deletion in
nociceptors reduced cold allodynia in a chronic pain
model (Carlin et al., 2018). The region adjacent to the
denervated area of the foot after sciatic nerve crush be-
comes hypersensitive to innocuous cold stimulation. To
test whether Tsc2 deletion affects pain behavior in a
sciatic nerve crush model, we performed an acetone test
weekly after injury to control-AAV8 and Tsc2 cKO-AAV8
mice. Cold allodynia was noted in both groups within one
week after nerve crush, and it resolved at four weeks
post-injury in both control-AAV8 and Tsc2 KO-AAV8 mice
(Fig. 9E). Interestingly, we observed an increase injury-
induced cold allodynia in Tsc2 KO-AAV8 mice at three
weeks post-crush compared to control-AAV8 mice, but
not in the acute or post-resolution phases (Fig. 9E). Adult
deletion of Tsc2 may increase injury-induced hypersensi-
tivity, which was not observed in Tsc2 cKO (Carlin et al.,
2018), suggesting that perinatal and adult activation of
mTORC1 signaling may have differing effects on some
pain responses. Together, these results with adult dele-
tion of Tsc2 yield further support to the notion that
mTORC1 activation in DRG neurons provides an initial but
unsustained enhancement of axon growth after nerve
injury.
Discussion
In the current study, we assessed the role mTORC1
activation via Tsc2 deletion in promoting axon growth in
peripheral nociceptive neurons after nerve injury. As this
signaling pathway is a well-known regulator of cellular
metabolism and protein translation (Saxton and Sabatini,
2017), we hypothesized that increased signaling would
result in an increased rate of regenerative axon growth. In
support of our previous findings (Abe et al., 2010), we
found that constitutive mTORC1 activation was able to
enhance axon growth in nociceptive neurons, but only
within 2 d after nerve injury, at which point the elongation
rate of control axons was able to catch up. Gene expres-
sion changes in uninjured Tsc2-deleted neurons, includ-
ing upregulated expression of RATFs known to be both
necessary and sufficient for promoting axon growth, are
likely to cause the enhanced early axon regeneration.
Consistent with the similar elongation rates of control and
Tsc2 cKO axons after the second day post-injury, Tsc2
deletion did not induce an additive effect on injury-
induced upregulation of RATFs or their targets. In addition
to changes in neuronal gene expression, neuronal Tsc2
deletion increased macrophage density in uninjured DRG
New Research 15 of 20
May/June 2019, 6(3) ENEURO.0168-19.2019 eNeuro.org
Figure 8. AAV8-mediated deletion of Tsc2 in adult mice induces a pro-regenerative environment in DRG. A, Immunohistochemistry
of uninjured L4 DRG stained for Tsc2 and Tubb3. Mice had intrathecal injections three weeks before a sciatic nerve crush. Uninjured
DRG were isolated 3 d post-injury. B, Quantification of percentage of Tsc2-positive neurons from A. C, Immunohistochemistry of
uninjured L4 DRG stained for cJun and Isl1. D, Quantification of percentage of cJun-positive neurons from C as well as linear
regression of cJun expression and infection efficiency for Tsc2 KO-AAV8 mice. E, Immunohistochemistry of uninjured L4 DRG stained
for Atf3 and Isl1. F, Quantification of percentage of Atf3-positive neurons from E as well as linear regression of Atf3 expression and
infection efficiency for Tsc2 KO-AAV8 mice. G, Immunohistochemistry of uninjured L4 DRG stained for Iba1 and Tubb3. Image from
DRG with high infection efficiency. H, Quantification of macrophage density by Iba1-positive area per neuron from G as well as linear
regression of macrophage density and infection efficiency for Tsc2 KO-AAV8 mice. N.S., not significant, p  0.01, p  0.001,
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as well as activated macrophages and satellite glial cells
in a similar manner as nerve injury. While mTORC1 inhi-
bition studies suggest that neuronal gene expression
changes are the main contributors to enhanced early
regeneration in Tsc2 cKO mice, some non-neuronal con-
tribution is also likely. We uncover a surprising amount of
overlap between the neuronal and non-neuronal pro-
regenerative programs of uninjured Tsc2 cKO and injured
control DRG. However, despite the extensive overlap in
the pro-regenerative programs of Tsc2 deletion and nerve
injury, Tsc2 deletion did not fully induced an injury-
conditioned state in cultured neurons suggesting that
continued
p  0.0001. Scale bars: 50 m. Extended Data Figure 8-1 shows data values of mean and SEM, number of replicates, statistical
tests, and values for all comparisons.
Figure 9. AAV8-mediated deletion of Tsc2 improves initial axon regeneration but not functional recovery after sciatic nerve crush
injury. A, Injured sciatic nerve stained with SCG10 to label regenerating axons 3 d after crush. Larger images of yellow boxed region
shown below whole nerve images. Red dotted line denotes the crush site while red arrowheads point to the three longest axons. Scale
bars: 500 m (top) and 50 m (bottom). B, C, Quantification of average of the ten longest axons 3 d following sciatic nerve crush from
(A) with linear regression (C) showing a lack of correlation between infection efficiency and length of longest axons. D, Paw withdrawal
threshold measurements using von Frey test for recovery of mechanical sensitivity in injured foot pad at noted times after sciatic nerve
crush. E, Time spent in pain behavior using acetone test for recovery from cold allodynia in uninjured and injured foot pad at noted
times after sciatic nerve crush; p  0.05. BL, baseline; D, post-operative day. Extended Data Figure 9-1 shows data values of mean
and SEM, number of replicates, statistical tests, and values for all comparisons.
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mTORC1 activation induces a partial pro-regenerative
program.
mTORC1 signaling promotes axon growth in multiple
types of neurons in both the central and PNSs (Park et al.,
2008; Abe et al., 2010; Liu et al., 2010). An important
distinction between the PNS and CNS is the intrinsic
regenerative growth capacity of adult peripheral axons
compared to the lack of growth competence of adult
central axons. Specifically, manipulation of signaling
pathways or transcription factors such as PI 3-kinase,
mTORC1, B-Raf, Stat3, c-Myc, Sox11, Klfs, and others is
required for axon regeneration after an optic nerve crush,
with manipulation of multiple pathways providing additive
or synergistic effects on axon elongation (Park et al.,
2008; Moore et al., 2009; Smith et al., 2009; Sun et al.,
2011; O’Donovan et al., 2014; Belin et al., 2015; Benowitz
et al., 2017; Norsworthy et al., 2017). Similar experiments
assessing manipulation of multiple pathways after periph-
eral nerve injury have been less common. A study in mice
with AAV-mediated co-deletion of both Pten and Socs3
showed marginal improvements in functional recovery
and 3-d regeneration after a sciatic nerve crush, although
relatively low infection efficiency limits the conclusions
that can be drawn on the true effect size of simultaneous
dysregulation of these pathways (Gallaher and Steward,
2018). Based on the optic nerve studies, it is likely that
altering multiple non-overlapping pathways will be re-
quired to induce robust increases in axon elongation. Our
analyses identified altered expression or activity of many
pro-regenerative transcription factors as a result of Tsc2
deletion, however many of these changes were more
robust in injured control neurons. Tsc2 deletion did not
increase the elongation rate in injury-conditioned axons,
which suggests that mTORC1 activity is not rate limiting in
peripheral sensory axon growth or that these processes
occur independently of Tsc2 or both. Additionally, nega-
tive regulators of growth may also be induced by
mTORC1 activation that act as a brake on long-term axon
growth enhancement. For example, our RNA-seq analysis
indicated that the effect of Tsc2 deletion on expression of
Rest, C/ebpd, and Smad2 target genes were inconsistent
with injured control neurons. Similarly, the mTORC1
downstream effector S6K1 was recently shown to nega-
tively regulate axon regeneration in cortical neurons by
suppressing PI 3-kinase activation through a mechanism
that may also function in DRG neurons (Melemedjian
et al., 2013; Al-Ali et al., 2017). Tsc2 deletion in DRG
neurons did not induce a complete regenerative pro-
gram, which may result from mechanistic differences in
activation between injury and Tsc2 deletion suggested
by their respective sensitivities to rapamycin or from
cell type-specific responses to Tsc2 deletion. A better
mechanistic understanding of the functions of
regeneration-associated signaling pathways and tran-
scription factors and their effects on specific neuronal
subtypes may uncover productive combinations of fac-
tors to manipulate for induction of synergistic regener-
ative axon growth in the periphery similar to what has
been observed in the optic nerve.
Our study focuses on the neuronal Tsc2/mTORC1 sig-
naling axis in the cell body, however mTORC1 signaling is
also active in both naïve and injured axons. An active form
of mTORC1 is present in uninjured A-fiber sensory axons,
and plantar administration of rapamycin inhibits re-
sponses to some painful stimuli (Jiménez-Díaz et al.,
2008). Nerve injury upregulates local translation of mTOR
protein in injured axons, which increases Stat3 signaling
and promotes proprioceptor survival (Terenzio et al.,
2018). A requirement for mTORC1 signaling in growth
cone dynamics has also been demonstrated in a number
of neuronal cell types including DRG neurons (Verma
et al., 2005; Nie et al., 2010; Poulopoulos et al., 2019).
Future studies will be needed to assess whether Tsc2
deletion is sufficient to activate the axonal pool of
mTORC1, and furthermore if increased axonal mTORC1
signaling has a different effect on axon elongation than
whole neuron Tsc2 deletion.
The effects of non-neuronal cells on axon regeneration
is an emerging field with limited data characterizing the
roles for different cell types. However, it is of no surprise
that a complex long-term process such as axon regener-
ation requires glial and immune support. In addition to
gene expression changes in neurons, we observed mac-
rophage and satellite glial cell activation as a result of
nociceptor deletion of Tsc2. A role for macrophage acti-
vation in inducing a pro-regenerative state in DRG as well
as myelin clearance in the sciatic nerve has been demon-
strated (for review, see Zigmond and Echevarria, 2019).
Specifically, Ccr2-mediated recruitment and activation of
M2 macrophages via Ccl2 signaling is both necessary and
sufficient for axon regeneration via activation of Stat3
(Kwon et al., 2015; Niemi et al., 2016). Our data show that
both M1 and M2 macrophages were activated in DRG by
nerve injury or nociceptor deletion of Tsc2 with accom-
panying activation of Stat3. This macrophage activation
may be accomplished via observed upregulation of Ccl8
expression or potentially through post-transcriptional up-
regulation of other Ccr2 ligands. Increased expression of
a number of chemokines including Ccl7 and Ccl8 was
noted in a recent microarray-based gene expression anal-
ysis after nerve injury (Cobos et al., 2018); however, this
study analyzed whole DRG lysates, precluding determi-
nation of the cellular source of expression changes. As
Ccl2 expression was unaffected by Tsc2 deletion, it is
possible that macrophage activation was also incomplete
as noted by the unchanged expression levels of CD163 in
Tsc2 cKO DRG. Incomplete activation of the M2 pheno-
type may partially explain the incomplete conditioning
response of uninjured Tsc2 cKO neurons in vitro.
Peripheral axons are relatively adept at axon regenera-
tion, suggesting that mTORC1 activation would not pro-
vide a significant therapeutic benefit after a nerve crush
injury based on our results. However, it will be important
to assess whether acute activation of mTORC1 signaling
can improve functional recovery of sensory neurons after
spinal cord injury or nerve repair surgery where initiation
of axon regeneration is less efficient. A conditioning sci-
atic nerve injury can promote axon regeneration after
spinal cord injury (Neumann and Woolf, 1999). Similarly,
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conditioning insults such as electrical stimulation or cap-
saicin treatment can induce pro-regenerative gene ex-
pression in DRG neurons improving axon outgrowth,
which can improve functional recovery after a nerve repair
(Frey et al., 2018; Senger et al., 2018, 2019; Poitras et al.,
2019). As mTORC1 activation in sensory neurons induces
pro-regenerative gene expression, short-term activation
of the pathway after dorsal column injury or before nerve
repair surgery may be sufficient to produce therapeuti-
cally relevant benefits in these severe cases.
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